The U.S. healthcare system was built around hospitals and physician offices. The next decade will be built around the home, and the shift is demographic before it's anything else. The oldest baby boomers turn 80 this year, by 2045 nearly 30% of Americans over 60 will be 80 or older, and someone turning 65 today has a 70% chance of needing long-term services.
Much of that care will be delivered through home health. Instead of keeping patients in a hospital, home health brings clinicians into the home: skilled nursing after surgery, physical and occupational therapy after a stroke, wound care, medication management, and ongoing support for chronic conditions. It's how a growing share of Americans will recover, age, and manage illness.
U.S. spend on home health has nearly quadrupled from $43.8 billion in 2004 to $169.4 billion in 2024, and is projected to reach $317 billion by 2033. Whether home health can absorb that growth depends on the agencies delivering care.
The Opportunity for Enzo Health:
The reality on the ground is messy. A single referral can arrive as a 40 to 50 page packet spread across hospital portals, fax, and email. Once a patient is admitted, nurses document hour-long visits on the go, juggling medications, family questions, safety issues, and OASIS, the assessment that drives both Medicare reimbursement and quality scores.
Enzo Health is the leading AI platform for home health. Enzo brings providers' intake, clinical, and back office operations into one system, automating workflows end-to-end. Where many agencies still run on on-prem EHRs built in the 90s and a stack of point solutions bolted on around them, Enzo replaces the patchwork with a single connected system.
The platform today centers on three products:
Enzo Intake analyzes referrals the moment they arrive, converting faxes, emails, hospital portals, and PDFs into structured data and checking eligibility and coverage in seconds, before staff review is needed.
Enzo Scribe records the visit and creates OASIS-ready documentation in real time, capturing medications and clinical detail and finishing the chart before the clinician leaves the home.
Enzo QA continuously reviews charts for clinical and regulatory accuracy, surfacing coding and compliance issues before they reach a payer and become denials, replacing the need for back-office teams of nurses reviewing every chart manually.
Our belief is that the opportunity for AI in home health is an end-to-end system, not disconnected point solutions: one platform from when a referral arrives to when the agency gets paid. That was the conviction behind our seed in 2024. Since then, Enzo has expanded from a QA focused product into an integrated suite that automates a majority of agency workflows.
Today, Enzo Health announced their $26M in total funding, including their $4M seed led by Gradient and their $20M Series A led by N47. Over the past 12 months, Enzo has grown revenue more than 40X and now powers organizations supporting more than 500,000 patients annually, including several of the largest agencies in the country.
We’re proud to have backed Zach, Dan, and the Enzo team. Today they're starting their expansion from home health into skilled nursing and hospice, continuing to raise the standard of care for the millions of Americans who will age, recover, and heal at home.